NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
06/04/2024
Back to search
Official data from USPTO
BLUEPOINT LABORATORIES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
50
Latest update
06/04/2024
Trademark type
Combined
Nice classes
5, 35
Filing date
02/26/2013
Registration date
11/18/2014
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/04/2024
Last transaction
06/04/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/15/2014
First use in commerce
09/15/2014
Drawing code
3
Owner type
16
Owner location
Conshohocken, PA
Examiner
DE JONGE, KATHLEEN
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the following: a solid circular dot from which a series of lines spiral outward to merge into a continuous perimeter rim. The spiral lines and rim are dark blue. The circular dot is medium blue. The color white separates the spiral lines. The word "BLUE" is dark blue and the word "POINT" is medium blue. The word "LABORATORIES" is black.
Holders and representatives
Holders
BluePoint Intellectual Property, LLC
BPL PHARMACEUTICALS HOLDING UNLIMITED COMPANY
BPL Pharmaceuticals Holding Company
Representatives
Patrick C. Stephenson Kutak Rock LLP
Technical classification
Nice Classes
Class 5Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for use in treating human diseasesthe treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders ; nutraceuticals for use as human dietary supplements; and health food supplements for use in treating human dietary deficiencies
Class 35
Wholesale distributorship services featuring pharmaceutical preparations for use in treating human diseasesnutraceuticals for use as human dietary supplementshealth food supplements for use in treating human dietary deficiencies
Publications
History of USPTO decisions and trademark events.
50 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
06/04/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/04/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/04/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
02/27/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
11/18/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/17/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/17/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/17/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/03/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/03/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/03/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/03/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/03/2021
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02/24/2021
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/24/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/18/2021
E815
TEAS SECTION 8 & 15 RECEIVED
11/11/2020
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
11/04/2020
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/18/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/27/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/20/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/20/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
11/18/2014
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/11/2014
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/10/2014
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/10/2014
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/10/2014
IUAF
USE AMENDMENT FILED
09/24/2014
EISU
TEAS STATEMENT OF USE RECEIVED
09/24/2014
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/29/2014
EX1G
SOU EXTENSION 1 GRANTED
03/27/2014
EXT1
SOU EXTENSION 1 FILED
03/27/2014
EEXT
SOU TEAS EXTENSION RECEIVED
03/27/2014
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/08/2013
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/01/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/06/2013
PUBO
PUBLISHED FOR OPPOSITION
08/06/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/17/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/28/2013
ALIE
ASSIGNED TO LIE
06/28/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/11/2013
XAEC
EXAMINER'S AMENDMENT ENTERED
06/10/2013
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/10/2013
GNEA
EXAMINERS AMENDMENT E-MAILED
06/10/2013
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/10/2013
DOCK
ASSIGNED TO EXAMINER
06/10/2013
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
03/06/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/05/2013
NWAP
NEW APPLICATION ENTERED
03/01/2013
Continuous trademark protection
Get notified about every new filing that threatens BLUEPOINT LABORATORIES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.